Ezbon International Ltd's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Dec 27, 2024
- Accession no.
- 0001062993-24-021228
- Filed
- Dec 27, 2024, 5:13 PM ET
- Trade date
- Dec 23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $23.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ezbon International LtdCIK 0001869027 | 10% Owner |
| Blue Horizon Enterprise LtdCIK 0001869057 | 10% Owner |
| Montrago Trustees LtdCIK 0001869331 | 10% Owner |
| Skorpios TrustCIK 0001869333 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | Common Stock | SSaleDisposed | −2,000,000 | $11.50 | −$23,000,000 | 6,906,181 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.